Drugs and Polymers for Delivery Systems in OA Joints: Clinical Needs and Opportunities
AbstractOsteoarthritis (OA) is a big burden of disease worldwide and one of the most common causes of disability in the adult population. Currently applied therapies consist of physical therapy, oral medication, intra-articular injections, and surgical interventions, with the main goal being to reduce pain and improve function and quality of life. Intra-articular (IA) administration of drugs has potential benefits in OA treatment because it minimizes systemic bioavailability and side effects associated with oral administration of drugs without compromising the therapeutic effect in the joint. However, IA drug residence time is short and there is a clinical need for a vehicle that is able to provide a sustained release long enough for IA therapy to fulfill its promise. This review summarizes the use of different polymeric systems and the incorporated drugs for IA drug delivery in the osteoarthritic joint with a primary focus on clinical needs and opportunities. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Janssen, M.; Mihov, G.; Welting, T.; Thies, J.; Emans, P. Drugs and Polymers for Delivery Systems in OA Joints: Clinical Needs and Opportunities. Polymers 2014, 6, 799-819.
Janssen M, Mihov G, Welting T, Thies J, Emans P. Drugs and Polymers for Delivery Systems in OA Joints: Clinical Needs and Opportunities. Polymers. 2014; 6(3):799-819.Chicago/Turabian Style
Janssen, Maarten; Mihov, George; Welting, Tim; Thies, Jens; Emans, Pieter. 2014. "Drugs and Polymers for Delivery Systems in OA Joints: Clinical Needs and Opportunities." Polymers 6, no. 3: 799-819.